SE437375B - Sett att framstella nya hogervridande isomerer av asymmetrisk spirohydantoin - Google Patents
Sett att framstella nya hogervridande isomerer av asymmetrisk spirohydantoinInfo
- Publication number
- SE437375B SE437375B SE7803626A SE7803626A SE437375B SE 437375 B SE437375 B SE 437375B SE 7803626 A SE7803626 A SE 7803626A SE 7803626 A SE7803626 A SE 7803626A SE 437375 B SE437375 B SE 437375B
- Authority
- SE
- Sweden
- Prior art keywords
- spirohydantoin
- compounds
- spiro
- acid
- fluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/799,586 US4130714A (en) | 1977-05-23 | 1977-05-23 | Hydantoin therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7803626L SE7803626L (sv) | 1978-11-24 |
SE437375B true SE437375B (sv) | 1985-02-25 |
Family
ID=25176274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7803626A SE437375B (sv) | 1977-05-23 | 1978-03-30 | Sett att framstella nya hogervridande isomerer av asymmetrisk spirohydantoin |
Country Status (37)
Country | Link |
---|---|
US (1) | US4130714A (de) |
JP (1) | JPS6035350B2 (de) |
AR (1) | AR219531A1 (de) |
AT (1) | AT357170B (de) |
AU (1) | AU499518B1 (de) |
BE (1) | BE867248A (de) |
CA (1) | CA1088073A (de) |
CH (1) | CH631455A5 (de) |
CS (1) | CS200550B2 (de) |
DD (1) | DD137107A5 (de) |
DE (2) | DE2858042C2 (de) |
DK (1) | DK147941C (de) |
EG (1) | EG13691A (de) |
ES (1) | ES470070A1 (de) |
FI (1) | FI62838C (de) |
FR (1) | FR2392024A1 (de) |
GB (1) | GB1572688A (de) |
GR (1) | GR68694B (de) |
HK (1) | HK53981A (de) |
HU (1) | HU177718B (de) |
IE (1) | IE47273B1 (de) |
IL (1) | IL54754A (de) |
IN (1) | IN147854B (de) |
IT (1) | IT1096306B (de) |
KE (1) | KE3168A (de) |
LU (1) | LU79685A1 (de) |
MY (1) | MY8200156A (de) |
NL (1) | NL7804158A (de) |
NO (1) | NO150206C (de) |
NZ (1) | NZ187334A (de) |
PH (1) | PH13828A (de) |
PL (1) | PL110460B1 (de) |
PT (1) | PT68071B (de) |
SE (1) | SE437375B (de) |
SU (1) | SU873885A3 (de) |
YU (1) | YU40829B (de) |
ZA (1) | ZA782919B (de) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
US4210667A (en) * | 1979-04-19 | 1980-07-01 | Pfizer Inc. | Pharmaceutical preparations containing coumarin carboxylic acid derivatives |
IE50332B1 (en) * | 1979-11-13 | 1986-04-02 | Ici Ltd | 1'-substituted-spiro(imidazolidine-4,3'-indoline)-2,2',5-triones,processes for their manufacture and pharmaceutical compositions thereof |
US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
US4286098A (en) * | 1980-03-28 | 1981-08-25 | Pfizer Inc. | Process for the preparation of chiral hydantoins |
JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
US4419521A (en) * | 1981-11-12 | 1983-12-06 | Pfizer Inc. | 6-Halo-4-chromanamines useful as intermediates to make chiral hydantoins |
JPS58124788A (ja) * | 1982-01-20 | 1983-07-25 | Eisai Co Ltd | 光学活性ヒダントイン誘導体,その製造方法ならびにそれを含有する治療用薬剤 |
US4436745A (en) | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
US4464385A (en) * | 1982-04-15 | 1984-08-07 | Alcon Laboratories, Inc. | Treatment of diabetic complications with hydantoins |
US4438272A (en) | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
US4540700A (en) * | 1982-04-15 | 1985-09-10 | Alcon Laboratories, Inc. | Treatment of diabetic complications with certain spiro-imidazolidine-diones |
US4431828A (en) * | 1982-11-10 | 1984-02-14 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil |
US4528387A (en) * | 1982-11-10 | 1985-07-09 | Pfizer Inc. | Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid |
US4556670A (en) * | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
US5153211A (en) * | 1983-09-14 | 1992-10-06 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
US4537892A (en) * | 1983-09-14 | 1985-08-27 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase |
DE3561198D1 (en) * | 1984-03-23 | 1988-01-28 | Pfizer | Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications |
US4600717A (en) * | 1984-04-11 | 1986-07-15 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in ophthalmic wound healing |
US4717725A (en) * | 1984-04-11 | 1988-01-05 | Alcon Laboratories, Inc. | Ophthalmic wound healing with aldose reductase inhibitors |
JPH06772B2 (ja) * | 1984-07-09 | 1994-01-05 | 鐘淵化学工業株式会社 | 3―(4―フルオロフエノキシ)プロピオニトリルを用いる6―フルオロ―4―クロマノンの製造法 |
HU198212B (en) * | 1984-07-20 | 1989-08-28 | Pfizer | Process for production of spiro-imidasolones |
WO1986001107A1 (en) * | 1984-08-14 | 1986-02-27 | Pfizer Inc. | Tetracyclic spiro-hydantoin aldose reductase inhibitors, compositions and methods of making |
ATE37371T1 (de) * | 1984-08-20 | 1988-10-15 | Pfizer | Verfahren zur herstellung asymmetrischer hydantoine. |
US4620019A (en) * | 1984-08-23 | 1986-10-28 | Pfizer Inc. | S-6-fluoro-4-aminochroman-4-carboxylic acid derivatives useful as intermediates for sorbinil |
US4609663A (en) * | 1984-09-11 | 1986-09-02 | Alcon Laboratories, Inc. | Aldose reductase inhibitors useful in glaucoma therapy |
US4551542A (en) * | 1984-09-26 | 1985-11-05 | Pfizer Inc. | Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid |
US5340829A (en) * | 1984-11-20 | 1994-08-23 | Washington Research Foundation | Immunoregulatory agents |
US4966911A (en) * | 1984-11-20 | 1990-10-30 | Washington Research Foundation | Immunoregulatory agents |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
WO1986007353A1 (en) | 1985-06-14 | 1986-12-18 | Pfizer Inc. | Intermediate in the production of an asymmetric hydantoin |
JPS627654U (de) * | 1985-06-26 | 1987-01-17 | ||
US4853410A (en) * | 1986-01-17 | 1989-08-01 | Pfizer Inc. | Hydroxyacetic acid derivatives for the treatment of diabetic complications |
JPS6357588A (ja) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤 |
AU598366B2 (en) * | 1987-03-20 | 1990-06-21 | Alcon Laboratories, Inc. | Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes |
US4841079A (en) * | 1987-08-07 | 1989-06-20 | Pfizer, Inc. | Process for the production of asymmetric hydantoins |
US5006657A (en) * | 1988-07-27 | 1991-04-09 | Pfizer Inc. | Intermediates in a resolution process for racemic spiro hydantoins |
US4952694A (en) * | 1988-07-27 | 1990-08-28 | Pfizer Inc. | Novel resolution process for racemic spiro-hydantoins |
AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
WO1992000071A1 (en) * | 1989-02-10 | 1992-01-09 | Washington Research Foundation | Immunoregulatory agents |
US4980357A (en) * | 1990-03-01 | 1990-12-25 | Pfizer Inc. | Azolidinedione derivatives |
US5039672A (en) * | 1990-04-05 | 1991-08-13 | Pfizer Inc. | Heterocyclic compounds as aldose reductase inhibitors |
US5236945A (en) * | 1990-06-11 | 1993-08-17 | Pfizer Inc. | 1H-indazole-3-acetic acids as aldose reductase inhibitors |
US5206367A (en) * | 1992-02-18 | 1993-04-27 | Pfizer Inc. | Preparation of optically active spiro-hydantoins |
NZ254550A (en) * | 1992-09-28 | 1997-08-22 | Pfizer | Use of nitrogen-substituted pyrimidines to prepare medicaments useful for treatment or prevention of diabetic complications |
US5521208A (en) * | 1993-07-29 | 1996-05-28 | Alcon Laboratories, Inc. | Compositions and methods for the treatment of the metabolically impaired and for improved compliance |
SK141899A3 (en) * | 1997-04-15 | 2000-09-12 | Csir Corporate Building | Pharmaceutical compositions having appetite suppressant activity |
GB2396815B (en) * | 1999-10-27 | 2004-09-08 | Phytopharm Plc | A composition comprising a pregnenone derivative and an NSAID |
GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
IL155710A0 (en) | 2000-11-30 | 2003-11-23 | Pfizer Prod Inc | Combination of gaba agonists and aldose reductase inhibitors |
US20110092566A1 (en) * | 2004-11-19 | 2011-04-21 | Srivastava Satish K | Treatment of cancer with aldose reductase inhibitors |
US8158667B2 (en) | 2006-08-21 | 2012-04-17 | Kador Peter F | Topical treatment of cataracts in dogs |
US8877717B2 (en) | 2007-03-12 | 2014-11-04 | Zadec Aps | Anti-diabetic extract of rooibos |
CA2685202C (en) | 2007-03-23 | 2017-11-28 | The Board Of Regents Of The University Of Texas System | Methods for treating allergic asthma |
US20090270490A1 (en) * | 2008-04-24 | 2009-10-29 | The Board Of Regents Of The University Of Texas System | Methods involving aldose reductase inhibition |
AU2011348074B2 (en) | 2010-12-23 | 2016-04-28 | The Board Of Regents Of The University Of Texas System | Methods for treating COPD |
UA118035C2 (uk) * | 2013-10-07 | 2018-11-12 | Сінгента Партісіпейшнс Аг | Гербіцидні сполуки |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2683718A (en) * | 1952-01-11 | 1954-07-13 | Searle & Co | Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione |
DE1135915B (de) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine |
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
-
1977
- 1977-05-23 US US05/799,586 patent/US4130714A/en not_active Expired - Lifetime
-
1978
- 1978-03-30 SE SE7803626A patent/SE437375B/sv not_active IP Right Cessation
- 1978-04-15 IN IN272/DEL/78A patent/IN147854B/en unknown
- 1978-04-19 PH PH21026A patent/PH13828A/en unknown
- 1978-04-19 NL NL7804158A patent/NL7804158A/xx active Search and Examination
- 1978-05-11 CS CS783021A patent/CS200550B2/cs unknown
- 1978-05-13 JP JP53057064A patent/JPS6035350B2/ja not_active Expired
- 1978-05-16 YU YU1169/78A patent/YU40829B/xx unknown
- 1978-05-16 PL PL1978206826A patent/PL110460B1/pl unknown
- 1978-05-17 SU SU782616255A patent/SU873885A3/ru active
- 1978-05-17 HU HU78PI625A patent/HU177718B/hu not_active IP Right Cessation
- 1978-05-18 AR AR272227A patent/AR219531A1/es active
- 1978-05-18 DD DD78205450A patent/DD137107A5/de unknown
- 1978-05-18 GB GB20352/78A patent/GB1572688A/en not_active Expired
- 1978-05-19 CA CA303,740A patent/CA1088073A/en not_active Expired
- 1978-05-19 AT AT365378A patent/AT357170B/de not_active IP Right Cessation
- 1978-05-19 DE DE2858042A patent/DE2858042C2/de not_active Expired
- 1978-05-19 BE BE187841A patent/BE867248A/xx not_active IP Right Cessation
- 1978-05-19 DE DE2821966A patent/DE2821966C2/de not_active Expired
- 1978-05-20 EG EG320/78A patent/EG13691A/xx active
- 1978-05-20 GR GR56282A patent/GR68694B/el unknown
- 1978-05-22 NZ NZ187334A patent/NZ187334A/en unknown
- 1978-05-22 AU AU36328/78A patent/AU499518B1/en not_active Expired
- 1978-05-22 LU LU79685A patent/LU79685A1/xx unknown
- 1978-05-22 PT PT68071A patent/PT68071B/pt unknown
- 1978-05-22 FI FI781613A patent/FI62838C/fi not_active IP Right Cessation
- 1978-05-22 NO NO781769A patent/NO150206C/no unknown
- 1978-05-22 DK DK226778A patent/DK147941C/da not_active IP Right Cessation
- 1978-05-22 ZA ZA00782919A patent/ZA782919B/xx unknown
- 1978-05-22 IL IL54754A patent/IL54754A/xx not_active IP Right Cessation
- 1978-05-22 ES ES470070A patent/ES470070A1/es not_active Expired
- 1978-05-22 IT IT23672/78A patent/IT1096306B/it active
- 1978-05-22 FR FR7815032A patent/FR2392024A1/fr active Granted
- 1978-05-22 IE IE1015/78A patent/IE47273B1/en not_active IP Right Cessation
- 1978-05-22 CH CH552778A patent/CH631455A5/fr not_active IP Right Cessation
-
1981
- 1981-10-15 KE KE3168A patent/KE3168A/xx unknown
- 1981-11-05 HK HK539/81A patent/HK53981A/xx unknown
-
1982
- 1982-12-30 MY MY156/82A patent/MY8200156A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE437375B (sv) | Sett att framstella nya hogervridande isomerer av asymmetrisk spirohydantoin | |
EP0881219B1 (de) | N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung | |
CS199690B2 (cs) | Způsob výroby spiro-hydantoinových derivátů | |
SU942597A3 (ru) | Способ получени спирооксазолидиндионов | |
SE437024B (sv) | Forfarande for framstellning av spiro-hydantoinforeningar | |
DE69018876T2 (de) | Pyridazinon-Derivate. | |
US4604406A (en) | N-[6-methoxy-5-(perfluoroalkyl)-1-naphtholyl]-N-methylglycines and their thionaphthoyl analogs | |
US4177282A (en) | Hydantoin therapeutic agents | |
FR2552433A1 (fr) | Nouveaux derives de 1,3,4-thiadiazole, procede pour leur preparation et leur utilisation comme agents anti-ulcere | |
JP2876144B2 (ja) | 3―フェニルクマリン―7―イルオキシ酢酸誘導体とその製法及び用途 | |
EP0005091B1 (de) | Monosubstituierte Piperazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
EP0395526B1 (de) | Benzothiazolinon-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
JPH05390B2 (de) | ||
EP0702015B1 (de) | Substituierte bizyklische Oxazol- und Thiazol-Äther | |
US3772378A (en) | 7-oxo-benzocycloheptene acetic acids | |
KR930006007A (ko) | 인돌술폰아미드 치환 디히드로피리딘, 그의 제조 방법 및 그의 의약으로서의 용도 | |
KR870000584B1 (ko) | 6-플루오로-4-우레이도크로만-4-카복실산으로부터 6-플루오로-4-크로만온의 재생방법 | |
EP0430800B1 (de) | Substituierte Benzothiazolinone, ihre Herstellung und sie enthaltende pharmazeutische Zusammenstellungen | |
JPH09169747A (ja) | 新規置換フェニルチアゾリジン−2,4−ジオン誘導体及びその製造法 | |
US4588526A (en) | Bronchodilatory azepino(1,2-A)pyrimidine derivatives and acid addition salts thereof and bronchodilating pharmaceutical compositions containing same | |
KR820001306B1 (ko) | 스피로-히단토인 화합물의 제조방법 | |
KR820001305B1 (ko) | 스피로-히단토인 화합물의 제조방법 | |
WO2012104538A1 (fr) | Nouveaux dérivés de 1, 5 - dihydropyrrol - 2 - one utiles pour le traitement paludisme ou d'autres maladies parasitaires et fongiques | |
JPH05509108A (ja) | 2,4−ジオキソ−ピリド[2,3−d]ピリミジン−3−酢酸及びそのエステルと塩 | |
JPH08245602A (ja) | ジオキソチアゾリジン誘導体及びそれを有効成分とする医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7803626-6 Effective date: 19941010 Format of ref document f/p: F |